Background Neoadjuvant chemotherapy for breast cancer was originally used in locally
advanced inoperable disease in order to achieve surgical resection. It was then extended to …

Learning Objectives After completing this course, the reader will be able to: Describe the
rationale for using primary systemic therapy (PST) in the treatment of nonmetastatic breast …

Purpose To develop a guideline for the use of sentinel node biopsy (SNB) in early stage
breast cancer. Methods An American Society of Clinical Oncology (ASCO) Expert Panel …

PURPOSE: To revise the American Joint Committee on Cancer staging system for breast
carcinoma. MATERIALS AND METHODS: A Breast Task Force submitted recommended …

Purpose Experience with sentinel node biopsy (SNB) after neoadjuvant chemotherapy is
limited. We examined the feasibility and accuracy of this procedure within a randomized trial …

Purpose To determine the detection rate, the false-negative rate, and the accuracy of
sentinel lymph node (SLN) detection after neoadjuvant chemotherapy (NAC) for advanced …

Background Sentinel lymph node (SLN) dissection has been investigated after neoadjuvant
chemotherapy and has shown mixed results. Our objective was to evaluate SLN dissection …

Objective: To evaluate factors affecting sentinel lymph node (SLN) identification after
neoadjuvant chemotherapy (NAC) in patients with initial node-positive breast cancer …

BACKGROUND. The feasibility and accuracy of sentinel lymph node (SLN) biopsy in
patients with breast cancer after preoperative chemotherapy has been demonstrated in a …

BACKGROUND The majority of patients with breast carcinoma receive chemotherapy as a
component of multimodality treatment. Over the past decade, it has become increasingly …